Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Understanding CMT4J: A Natural History Study
The purpose of this study is to observe and understand the progression of CMT4J over time. By tracking the natural course of the disease, researchers aim to discover how CMT4J…
Links to CMTA Resources
Learn more CMTA Webinars: www.cmtausa.org/webinars STAR Research: www.cmtausa.org/our-research Dr. Scherer on Pain: www.cmtausa.org/painpdf Ask the Experts: www.cmtausa.org/cmtexperts Neurotoxic Drug List: www.cmtausa.org/medicationlist Connect with us CMTA Facebook Page: www.facebook.com/CMTAssociation…
Medications and Charcot-Marie-Tooth Disease
There currently are no available treatments that act to slow the progression of Charcot-Marie-Tooth disease. There are promising CMT research studies that indicate that this may change in the near…
A Retrospective Study of Subjects with Mutations in the C12ORF65 Gene Causing Complex CMT Type 6
…carries out specialist research into neurodegenerative diseases at the University of Cambridge and Addenbrooke’s Hospital. As a participant in this study, you would be asked to take part in a…
CMTA Updates List of Neurotoxic Meds Potentially More Hazardous to CMT Patients
…their families. The CMTA has invested $23.5 million in the search for a cure and its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers together with pharmaceutical and biotechnology…
Keys for A Cure: A Resonate Concert for CMT
Keys for A Cure: A Resonate Concert for CMT is a virtual fundraiser aimed at raising awareness and funds to support Charcot-Marie-Tooth disease research. Hosted by CMTA’s Western Canada Branch…
CMTA Appoints David Apple to Board of Directors
…for a cure and its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers together with pharmaceutical and biotechnology partners and patients to accelerate scientific breakthroughs. The CMTA also offers…
Sperm Donor with Gene for Charcot-Marie-Tooth Disease Passes It on to Multiple Families
…for patients and their families. The CMTA has invested $23.5 million in the search for a cure and its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers together with…
Hereditary Sensory Neuropathy Serine trial (SENSE trial)
In December 2021, the Charcot-Marie-Tooth Association Strategy to Accelerate Research (CMTA-STAR) awarded Dr. Mary M. Reilly and her team at the UCL Queen Square Institute of Neurology in London $354,826…
Applied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency
NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications…